MedicarePartD.guide

A non-government resource built from CMS public data

RYALTRIS 665/25 ug Spray, Metered

Also known as Olopatadine Hydrochloride And Mometasone Furoate. Coverage in Indiana and Kentucky (CMS PDP Region 15).

3 of 10 stand-alone Part D plans in Indiana and Kentucky cover this drug on tier 3–4.

2 of 3 plans apply a prior authorization, step therapy or quantity limit.

42 Medicare Advantage plans in IN, KY do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. IN: 22 plans · KY: 20 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Preferred from UHC (PDP)$127.10/mo premium · $130.00 deductible3Preferred Brand18%18%$8.2216—None
HealthSpring Extra Rx (PDP)$78.20/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$7.6085—
  • Step therapy
HealthSpring Assurance Rx (PDP)$117.80/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$7.6259—
  • Step therapy

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →